Trinity Biotech Statistics
NASDAQ: TRIBHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
6.75-0.40 (-5.59%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Trinity Biotech by the numbers
Trinity Biotech has a market capitalization of $5.5 million based on 813.13K shares outstanding. With trailing EPS of $-60.00, Trinity Biotech is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 28.3% below its 50-day average and 60.4% below its 200-day average.
Average daily trading volume is 21.83K shares, or about $147,326 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
TRIB valuation vs. peer median
| Metric | TRIB | Peer median | Difference |
|---|---|---|---|
| Market cap | $5.49M | $7.79M | -30% |
| Avg. volume | 21.83K | 191.68K | -89% |
Peer median across 8 companies: CDIO, QCLS, VNRX, VRAX, BMRA, ICCC, IMDX, NNNN.
Valuation
- Market cap
- $5.49M
- EPS (TTM)
- $-60.00
- Shares outstanding
- 813.13K
Price and trading
- Previous close
- 7.15
- Open
- 7.01
- Day range
- 6.71 – 7.16
- 52-week range
- 5.01 – 52.50
- Beta
- —
- Volume
- 9.38K
- Average volume
- 21.83K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 13, 2025
Additional statistics
- Market Cap
- 5.49M
- Forward Pe
- -6.55
- Eps
- -60.00
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 52.50
- Week52 Low
- 5.01
- Avg Volume
- 21,826.00
- Shares Outstanding
- 813.13K
- Ma50
- 9.42
- Ma200
- 17.05
- Earnings Date
- Aug 13, 2025
- Pct From52w High
- -87.14%
- Pct From52w Low
- 34.73%